NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Acorda Therapeutics, Inc. (“Acorda” or the “Company”) (NASDAQ:ACOR) violated federal securities laws.
Click here to learn about the case: http://docs.wongesq.com/ACOR-Info-Request-Form-1734 . There is no cost or obligation to you.
On November 15, 2017, Acorda revealed it had ceased enrolling new patients in its Phase 3 trial of its Parkinson’s treatment due to patient deaths.
To learn more about the investigation of Acorda contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/ACOR-Info-Request-Form-1734 .
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
